Massmedica S.A. (WSE:MSM)
Poland · Delayed Price · Currency is PLN 4.200
+0.070 (1.69%)
At close: Jun 11, 2026
Massmedica Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 28.97 | 32.62 | 26.37 | 24.83 | 21.61 | 18.19 | |
Revenue Growth (YoY) | -11.86% | 23.71% | 6.21% | 14.89% | 18.78% | -3.01% |
Cost of Revenue | 16.52 | 19.29 | 16.6 | 15.27 | 12.86 | 10.96 |
Gross Profit | 12.45 | 13.33 | 9.77 | 9.56 | 8.75 | 7.23 |
Selling, General & Admin | 8.41 | 8.55 | 7.03 | 6.8 | 6.87 | 5.53 |
Other Operating Expenses | 2.21 | 2.92 | 1.37 | 1.28 | 0.85 | 0.49 |
Operating Expenses | 10.92 | 11.8 | 8.67 | 8.67 | 8.1 | 6.4 |
Operating Income | 1.52 | 1.53 | 1.1 | 0.88 | 0.65 | 0.83 |
Interest Expense | -0.15 | -0.01 | -0.02 | -0.02 | -0.04 | -0.05 |
Interest & Investment Income | 0.01 | 0.01 | 0.03 | 0.02 | - | - |
Currency Exchange Gain (Loss) | -0.08 | -0.08 | -0.02 | -0.02 | - | - |
Other Non Operating Income (Expenses) | -0.41 | -0.38 | -0.38 | -0.28 | -0.08 | 0.01 |
EBT Excluding Unusual Items | 0.9 | 1.07 | 0.7 | 0.58 | 0.53 | 0.79 |
Gain (Loss) on Sale of Assets | - | - | -0 | -0 | -0.04 | -0.01 |
Pretax Income | 0.9 | 1.07 | 0.7 | 0.58 | 0.5 | 0.78 |
Income Tax Expense | 0.22 | 0.25 | 0.19 | 0.17 | 0.15 | 0.18 |
Net Income | 0.68 | 0.81 | 0.51 | 0.41 | 0.35 | 0.6 |
Net Income to Common | 0.68 | 0.81 | 0.51 | 0.41 | 0.35 | 0.6 |
Net Income Growth | -22.81% | 59.11% | 24.52% | 17.83% | -42.06% | 41.18% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 |
EPS (Basic) | 0.28 | 0.34 | 0.21 | 0.17 | 0.14 | 0.25 |
EPS (Diluted) | 0.28 | 0.34 | 0.21 | 0.17 | 0.14 | 0.25 |
EPS Growth | -22.81% | 59.11% | 24.52% | 17.83% | -42.06% | 41.18% |
Free Cash Flow | 0.39 | -0.13 | -0.57 | 0.07 | -1.69 | 1.18 |
Free Cash Flow Per Share | 0.16 | -0.06 | -0.23 | 0.03 | -0.70 | 0.49 |
Gross Margin | 42.97% | 40.87% | 37.04% | 38.50% | 40.49% | 39.73% |
Operating Margin | 5.25% | 4.69% | 4.15% | 3.56% | 3.01% | 4.57% |
Profit Margin | 2.33% | 2.50% | 1.94% | 1.66% | 1.62% | 3.31% |
Free Cash Flow Margin | 1.33% | -0.41% | -2.15% | 0.29% | -7.82% | 6.48% |
EBITDA | 1.77 | 1.86 | 1.37 | 1.47 | 1.03 | 1.21 |
EBITDA Margin | 6.12% | 5.71% | 5.20% | 5.94% | 4.77% | 6.66% |
D&A For EBITDA | 0.25 | 0.33 | 0.28 | 0.59 | 0.38 | 0.38 |
EBIT | 1.52 | 1.53 | 1.1 | 0.88 | 0.65 | 0.83 |
EBIT Margin | 5.25% | 4.69% | 4.15% | 3.56% | 3.01% | 4.57% |
Effective Tax Rate | 24.47% | 23.82% | 26.71% | 29.20% | 29.57% | 22.55% |
Revenue as Reported | - | - | - | 24.83 | 21.61 | 18.19 |